|
||
Journal of Experimental Medicine, Vol 169, 1557-1564, Copyright © 1989 by Rockefeller University Press
ARTICLES |
A Wright, JE Lee, MP Link, SD Smith, W Carroll, R Levy, C Clayberger and AM Krensky
Department of Pediatrics, Stanford University School of Medicine, California 94305.
CTL are thought to play a role in the elimination of transformed cells in vivo. The effectiveness of such CTL is in part dependent on recognition of tumor specific antigens. Among the best characterized tumor-specific antigens are the unique or idiotypic determinants on the Ig of B cell lymphomas. Here we describe the generation and properties of human CTL specific for the idiotype on autologous B cell tumors. These cells are CD3+,CD4-,CD8- and express the delta chain of the TCR. Such cells may prove useful in tumor-specific adoptive therapy.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|